N-Acetyl Cysteine 관련 Post-Concussion Cognitive Symptoms

NAC demonstrated neuroprotective effects in traumatic brain injury models. MRI studies showed improvements in resting-state brain connectivity in mild TBI patients receiving NAC treatment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Dpost\u002Dconcussion'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

NAC demonstrated neuroprotective effects in traumatic brain injury models. MRI studies showed improvements in resting-state brain connectivity in mild TBI patients receiving NAC treatment.

Key Study Findings

Randomized Controlled Trial n=50 Open-label

Changes in Resting-State Functional Connectivity and Cognitive-Affective Symptoms in Patients With Post-Concussion Syndrome Treated With …

Dose: None vs: waitlist control (standard of care) Outcome: resting-state functional connectivity and cognitive-affective symptoms 효과: None p<0.05

대상 집단: patients with chronic post-concussion syndrome for at least 3 months

Review

Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols.

Dose: None vs: None Outcome: TBI prevention and neuroprotection 효과: None None

대상 집단: Individuals with or at risk for TBI

Controlled Clinical Trial n=65 4 weeks Open-label

N -acetylcysteine is associated with reduction of postconcussive symptoms in elderly patients: A pilot study.

Dose: None vs: Standard care alone Outcome: RPQ postconcussion symptom severity 효과: RPQ day 7: 2 vs 10; day 30: 0 vs 4 p=0.004 (day 7); p=0.021 (day

대상 집단: Elderly patients (>=60y) with mild TBI

Review

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.

Dose: None vs: None Outcome: None 효과: None None

대상 집단: restless legs syndrome

Review

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Review

Dietary Supplements for Health, Adaptation, and Recovery in Athletes.

Dose: None vs: None Outcome: Health, adaptation, and recovery in athletes 효과: None None

대상 집단: Athletes

Key Statistics

연구

400

참여자

↑

Positive

등급

Referenced Papers

Changes in Resting-State Functional Connectivity and Cognitive-Affective Symptoms in Patients With Post-Concussion Syndrome Treated With N-Acetyl Cysteine. RCT

The Journal of … None

Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols. Review

Nutrients 2024 22 인용

N -acetylcysteine is associated with reduction of postconcussive symptoms in elderly patients: A pilot study. Other

The journal of … 2022 7 인용

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Review

Sleep medicine clinics 2021 14 인용

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Review

Neuroscience and biobehavioral … 2019 45 인용

Dietary Supplements for Health, Adaptation, and Recovery in Athletes. Review

International journal of … 2018 165 인용

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging. Other

Canadian journal of … 2018 37 인용

Restless legs syndrome. Review

Handbook of clinical … 2011 8 인용

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:: 600-1,800 mg/day
neuroprotection:: 1,200-2,400 mg/day

상한량: Not established as supplement; 6,000+ mg/day used clinically (IV)

연구에서 사용된 용량

용량	기간	효과	N
None	--	Positive	50
None	--	Positive	--
None	4 weeks	Positive	65
None	--	Mixed	--
None	--	Positive	--
None	--	Mixed	--
NAC 100 mg/kg body weight orally daily for 14 days	2 weeks	Positive	24
None	--	Mixed	--

권장 복용 시간: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

보고된 부작용

⚠ Nausea and vomiting
⚠ Diarrhea
⚠ Unpleasant sulfur taste/smell
⚠ Rare: bronchospasm (inhaled form)
⚠ Long-term use may deplete zinc stores

알려진 상호작용

● Nitroglycerin (may enhance hypotensive effects)
● Activated charcoal (reduces NAC absorption)
● Anticoagulants (theoretical interaction)

일일 최대 섭취 허용량: Not established as supplement; 6,000+ mg/day used clinically (IV)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Post-Concussion Cognitive Symptoms?

Based on 6 studies with 400 participants, there is moderate evidence from clinical studies that N-Acetyl Cysteine may support Post-Concussion Cognitive Symptoms management. Our evidence grade is B (Good Evidence).

How much N-Acetyl Cysteine should I take for Post-Concussion Cognitive Symptoms?

Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of N-Acetyl Cysteine?

Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for N-Acetyl Cysteine and Post-Concussion Cognitive Symptoms?

We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

N-Acetyl Cysteine 다른 건강 상태에 대한 근거

Oxidative Stress & Neuroinflammation B Depression-Related Cognitive Dysfunction C

한눈에 보기

NAC demonstrated neuroprotective effects in traumatic brain injury models. MRI studies showed improvements in resting-state brain connectivity in mild TBI patients receiving NAC treatment.

Evidence Strength72%

High confidence

연구 분석

RCT (1)Meta (0)Other (5)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: Post-Concussion Cognitive Symptoms

자세히 알아보기

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.